228 related articles for article (PubMed ID: 33317545)
1. Musashi-1 promotes cancer stem cell properties of glioblastoma cells via upregulation of YTHDF1.
Yarmishyn AA; Yang YP; Lu KH; Chen YC; Chien Y; Chou SJ; Tsai PH; Ma HI; Chien CS; Chen MT; Wang ML
Cancer Cell Int; 2020 Dec; 20(1):597. PubMed ID: 33317545
[TBL] [Abstract][Full Text] [Related]
2. Musashi-1 Enhances Glioblastoma Migration by Promoting ICAM1 Translation.
Lin JC; Tsai JT; Chao TY; Ma HI; Liu WH
Neoplasia; 2019 May; 21(5):459-468. PubMed ID: 30959276
[TBL] [Abstract][Full Text] [Related]
3. Musashi-1 regulates AKT-derived IL-6 autocrinal/paracrinal malignancy and chemoresistance in glioblastoma.
Chen HY; Lin LT; Wang ML; Lee SH; Tsai ML; Tsai CC; Liu WH; Chen TC; Yang YP; Lee YY; Chang YL; Huang PI; Chen YW; Lo WL; Chiou SH; Chen MT
Oncotarget; 2016 Jul; 7(27):42485-42501. PubMed ID: 27285760
[TBL] [Abstract][Full Text] [Related]
4. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
[TBL] [Abstract][Full Text] [Related]
5. Musashi-1 Enhances Glioblastoma Cell Migration and Cytoskeletal Dynamics through Translational Inhibition of Tensin3.
Chen HY; Lin LT; Wang ML; Laurent B; Hsu CH; Pan CM; Jiang WR; Chen PY; Ma HI; Chen YW; Huang PI; Chiou A; Chiou SH
Sci Rep; 2017 Aug; 7(1):8710. PubMed ID: 28821879
[TBL] [Abstract][Full Text] [Related]
6. YTHDF1 Regulates Tumorigenicity and Cancer Stem Cell-Like Activity in Human Colorectal Carcinoma.
Bai Y; Yang C; Wu R; Huang L; Song S; Li W; Yan P; Lin C; Li D; Zhang Y
Front Oncol; 2019; 9():332. PubMed ID: 31131257
[TBL] [Abstract][Full Text] [Related]
7. Musashi-1 Regulates MIF1-Mediated M2 Macrophage Polarization in Promoting Glioblastoma Progression.
Yang YP; Chien CS; Yarmishyn AA; Chan MS; Lee AC; Chen YW; Huang PI; Ma HI; Lo WL; Chien Y; Lin WC; Wang ML; Chen MT
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33918794
[TBL] [Abstract][Full Text] [Related]
8. miR-671-5p Inhibition by MSI1 Promotes Glioblastoma Tumorigenesis via Radioresistance, Tumor Motility and Cancer Stem-like Cell Properties.
Lin JC; Kuo CY; Tsai JT; Liu WH
Biomedicines; 2021 Dec; 10(1):. PubMed ID: 35052701
[TBL] [Abstract][Full Text] [Related]
9. Luteolin inhibits Musashi1 binding to RNA and disrupts cancer phenotypes in glioblastoma cells.
Yi C; Li G; Ivanov DN; Wang Z; Velasco MX; Hernández G; Kaundal S; Villarreal J; Gupta YK; Qiao M; Hubert CG; Hart MJ; Penalva LOF
RNA Biol; 2018; 15(11):1420-1432. PubMed ID: 30362859
[TBL] [Abstract][Full Text] [Related]
10. Musashi-1 promotes chemoresistant granule formation by PKR/eIF2α signalling cascade in refractory glioblastoma.
Chen HY; Lin LT; Wang ML; Tsai KL; Huang PI; Yang YP; Lee YY; Chen YW; Lo WL; Lan YT; Chiou SH; Lin CM; Ma HI; Chen MT
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1850-1861. PubMed ID: 29486283
[TBL] [Abstract][Full Text] [Related]
11. Oncogene c-Myc promotes epitranscriptome m
Nishizawa Y; Konno M; Asai A; Koseki J; Kawamoto K; Miyoshi N; Takahashi H; Nishida N; Haraguchi N; Sakai D; Kudo T; Hata T; Matsuda C; Mizushima T; Satoh T; Doki Y; Mori M; Ishii H
Oncotarget; 2018 Jan; 9(7):7476-7486. PubMed ID: 29484125
[TBL] [Abstract][Full Text] [Related]
12. YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner.
Chen H; Yu Y; Yang M; Huang H; Ma S; Hu J; Xi Z; Guo H; Yao G; Yang L; Huang X; Zhang F; Tan G; Wu H; Zheng W; Li L
Cell Biosci; 2022 Feb; 12(1):19. PubMed ID: 35197112
[TBL] [Abstract][Full Text] [Related]
13. The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation.
Liu T; Wei Q; Jin J; Luo Q; Liu Y; Yang Y; Cheng C; Li L; Pi J; Si Y; Xiao H; Li L; Rao S; Wang F; Yu J; Yu J; Zou D; Yi P
Nucleic Acids Res; 2020 Apr; 48(7):3816-3831. PubMed ID: 31996915
[TBL] [Abstract][Full Text] [Related]
14. Expression profiles and prognostic significance of RNA N6-methyladenosine-related genes in patients with hepatocellular carcinoma: evidence from independent datasets.
Zhou Y; Yin Z; Hou B; Yu M; Chen R; Jin H; Jian Z
Cancer Manag Res; 2019; 11():3921-3931. PubMed ID: 31118805
[No Abstract] [Full Text] [Related]
15. The m
Diao H; Tan H; Hu Y; Wang R; Cai P; Huang B; Shao X; Yan M; Yin C; Zhang Y
Pharmaceuticals (Basel); 2023 Jan; 16(2):. PubMed ID: 37259333
[TBL] [Abstract][Full Text] [Related]
16. YTHDF1 amplification is correlated with worse outcome and lower immune cell infiltrations in breast cancer.
Li C; Zhang C; Zhang G; Chen B; Li X; Li K; Ren C; Wen L; Liao N
Cancer Biomark; 2022; 35(2):127-142. PubMed ID: 35342079
[TBL] [Abstract][Full Text] [Related]
17. M6A RNA Methylation Regulator HNRNPC Contributes to Tumorigenesis and Predicts Prognosis in Glioblastoma Multiforme.
Wang LC; Chen SH; Shen XL; Li DC; Liu HY; Ji YL; Li M; Yu K; Yang H; Chen JJ; Qin CZ; Luo MM; Lin QX; Lv QL
Front Oncol; 2020; 10():536875. PubMed ID: 33134160
[TBL] [Abstract][Full Text] [Related]
18. MSI1 Promotes the Expression of the GBM Stem Cell Marker CD44 by Impairing miRNA-Dependent Degradation.
Pötschke R; Haase J; Glaß M; Simmermacher S; Misiak C; Penalva LOF; Kühnöl CD; Hüttelmaier S
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33291443
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic Role of an Epigenetic Reader of m
Orouji E; Peitsch WK; Orouji A; Houben R; Utikal J
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31947544
[TBL] [Abstract][Full Text] [Related]
20. The m6A readers
Anita R; Paramasivam A; Priyadharsini JV; Chitra S
Am J Cancer Res; 2020; 10(8):2546-2554. PubMed ID: 32905518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
